News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,922 Results
Type
Article (88784)
Company Profile (816)
Press Release (794300)
Multimedia
Podcasts (238)
Webinars (35)
Section
Business (233595)
Career Advice (4162)
Deals (39989)
Drug Delivery (177)
Drug Development (91706)
Employer Resources (207)
FDA (18553)
Job Trends (17487)
News (398737)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (57)
ADA (49)
Adcomms (40)
Allergies (201)
Alliances (56990)
ALS (237)
Alzheimer's disease (1969)
Antibody-drug conjugate (ADC) (552)
Approvals (18899)
Artificial intelligence (871)
ASCO (345)
Autoimmune disease (362)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (839)
Cancer (6586)
Cardiovascular disease (554)
Career advice (3597)
Career pathing (52)
CAR-T (385)
CDC (76)
Celiac Disease (3)
Cell therapy (1071)
Cervical cancer (54)
Clinical research (79021)
Collaboration (2371)
Company closure (8)
Compensation (1517)
Complete response letters (106)
COVID-19 (3041)
CRISPR (125)
C-suite (1285)
Cystic fibrosis (167)
Data (8707)
Decentralized trials (3)
Denatured (91)
Depression (193)
Dermatology (97)
Diabetes (705)
Diagnostics (7601)
Digital health (70)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (427)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (318)
Earnings (102486)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138677)
Executive appointments (1193)
FDA (22626)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1946)
Gene editing (272)
Generative AI (90)
Gene therapy (849)
GLP-1 (1286)
Government (5560)
Grass and pollen (8)
Guidances (420)
Healthcare (21264)
Hematology (198)
HIV (95)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (353)
Immuno-oncology (116)
Indications (207)
Infectious disease (3441)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (149)
Intellectual property (323)
Interviews (821)
IPO (18003)
IRA (61)
Job creations (5209)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (687)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (873)
Lymphoma (472)
Machine learning (66)
Management (66)
Manufacturing (1223)
MASH (226)
Medical device (15280)
Medtech (15440)
Mergers & acquisitions (23294)
Metabolic disorders (1826)
mRNA (266)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (509)
Neuropsychiatric disorders (127)
Neuroscience (3718)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5146)
Now hiring (80)
Obesity (872)
Opinion (374)
Ovarian cancer (244)
Pain (285)
Pancreatic cancer (352)
Parkinson's disease (417)
Partnered (39)
Patents (655)
Patient recruitment (763)
Peanut (71)
People (68004)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24420)
Phase 2 (34321)
Phase 3 (25814)
Pipeline (9766)
Policy (398)
Postmarket research (3560)
Preclinical (10984)
Press Release (72)
Prostate cancer (349)
Psychedelics (69)
Radiopharmaceuticals (373)
Rare diseases (1266)
Real estate (7462)
Recruiting (81)
Regulatory (30393)
Reports (77)
Research institute (2771)
Resumes & cover letters (654)
Rett syndrome (43)
RNA editing (29)
RSV (98)
Schizophrenia (196)
Series A (328)
Series B (238)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4372)
State (2)
Stomach cancer (21)
Supply chain (146)
Tariffs (104)
The Weekly (144)
Vaccines (1306)
Venture capital (134)
Weight loss (598)
Women's health (141)
Worklife (24)
Date
Today (36)
Last 7 days (632)
Last 30 days (2842)
Last 365 days (33195)
2026 (16285)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (403)
Arkansas (16)
Asia (52301)
Australia (9193)
California (14388)
Canada (4016)
China (1575)
Colorado (620)
Connecticut (641)
Delaware (445)
Europe (120614)
Florida (2134)
Georgia (467)
Hawaii (4)
Idaho (70)
Illinois (1255)
India (103)
Indiana (665)
Iowa (25)
Japan (594)
Kansas (143)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1745)
Massachusetts (10530)
Michigan (422)
Minnesota (801)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (153)
New Hampshire (92)
New Jersey (3815)
New Mexico (35)
New York (3787)
North Carolina (1939)
North Dakota (11)
Northern California (7155)
Ohio (449)
Oklahoma (27)
Oregon (55)
Pennsylvania (2834)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5644)
Tennessee (228)
Texas (2344)
United States (51492)
Utah (427)
Vermont (1)
Virginia (365)
Washington D.C. (89)
Washington State (1184)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 883,922 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million
June 15, 2026
·
4 min read
Press Releases
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
June 15, 2026
·
7 min read
Press Releases
Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
June 15, 2026
·
14 min read
Press Releases
Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
June 15, 2026
·
4 min read
Press Releases
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival
June 15, 2026
·
12 min read
Press Releases
Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
June 15, 2026
·
12 min read
Rare diseases
Consummate chameleon Amylyx nears regulatory run in obesity surgery complication
After suffering the market withdrawal of its only product, Amylyx is gearing up for a pivotal Phase 3 readout in post-bariatric hypoglycemia. But the company’s driving ethos is still to treat “debilitating, devastating” neurodegenerative diseases, co-CEO Justin Klee told
BioSpace
.
June 15, 2026
·
5 min read
·
Heather McKenzie
Press Releases
Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
June 15, 2026
·
8 min read
Psychedelics
How does ibogaine work? Understanding matrix logic to make a safer drug
Ibogaine’s unconventional “matrix pharmacology” may underlie both its therapeutic promise and unpredictable cardiac risks. Unraveling this mechanism could help drug developers hoping to bring ibogaine analogs to market.
June 15, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma
June 14, 2026
·
38 min read
1 of 88,393
Next
